Related Experiment Video
Updated: Jun 18, 2026

11:48
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Propofol suppresses prostaglandin E(2) production in human peripheral monocytes
Tomoko Kambara1, Takefumi Inada, Kozue Kubo
1Department of Anesthesiology, Kansai Medical University, Osaka, Japan.
Immunopharmacology and Immunotoxicology
|December 3, 2009
Summary
Propofol, a common anesthetic, suppresses prostaglandin E2 production in immune cells. This occurs by inhibiting cyclooxygenase-2 activity, impacting inflammation and immunity.
Area of Science:
- Immunology
- Anesthesiology
- Biochemistry
Background:
- Prostaglandin E2 (PGE2) from monocytes/macrophages is crucial for immune and inflammatory responses.
- Propofol is a widely used intravenous anesthetic, often administered to immunocompromised patients.
Purpose of the Study:
- To investigate the effect of propofol on prostaglandin E2 production in human monocytes.
- To elucidate the mechanism by which propofol influences PGE2 synthesis.
Main Methods:
- Human peripheral monocytes were activated with lipopolysaccharide.
- The effect of propofol on PGE2 production and cyclooxygenase-2 (COX-2) activity was measured.
Main Results:
- Propofol significantly suppressed PGE2 production in activated human monocytes.
- The suppressive effect was attributed to the inhibition of COX-2 enzyme activity, not changes in protein expression or substrate availability.
Conclusions:
- Propofol exerts a notable influence on immune and inflammatory processes.
- Propofol's inhibition of COX-2 activity suggests a direct impact on monocyte-mediated inflammation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
